Law­mak­ers halt push for drug prices in TV ads

In an ef­fort to get the first set of FY 2019 ap­pro­pri­a­tions bills to the Pres­i­dent’s desk, US House lead­ers scrapped a bi­par­ti­san amend­ment that would have re­quired drug­mak­ers to in­clude list prices in di­rect-to-con­sumer (DTC) tele­vi­sion ads.

The amend­ment — spon­sored by Sens. Dick Durbin (D-IL) and Chuck Grass­ley (R-IA) — was of­fered and sub­se­quent­ly with­drawn dur­ing a joint con­fer­ence com­mit­tee of the House and Sen­ate, de­spite pass­ing the Sen­ate last month. The move was fol­lowed by fin­ger point­ing.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.